close

Enter

Log in using OpenID

Closed Blood Sampling System Market

embed
Closed blood sampling system is a closed, needle free blood sampling system that reduces blood waste and minimizes the risk of transmission of infectious diseases.
Closed Blood Sampling System Market Research and Analysis By
Experts: Import/Export details, Cost Structures and Market
statistics Till 2018 With Global Key Players Edwards Lifesciences
Crop, ICU Medical, Inc., Smiths Medical, CardioMed Supplies
Inc.
Closed blood sampling system is a closed, needle free blood sampling system that reduces blood
waste and minimizes the risk of transmission of infectious diseases. Closed blood sampling
system aims to increase the efficiency of the blood sampling process, especially in the cases of
critically ill patients suffering from severe injuries or trauma. The closed blood sampling system
has a reservoir, which allows blood storage and minimize repeated blood isolation from the site
of sampling such as antecubital area, hand or wrist or foot. The unused blood in the reservoir
can be re-infused into the same patient. The global closed blood sampling market is driven by
factors such as rising incidence of surgeries and trauma as well as advantages of closed blood
sampling system over the conventional techniques.
Closed blood sampling systems require less blood as compared to open blood sampling system,
thus leading to less blood loss in patients. Moreover, implementing closed blood sampling
systems significantly reduces iatrogenic anemia, thereby reducing the necessity for blood
transfusions and minimizing possible risk of negative transfusion effects. However, lack of
implementation of this process and lack of professionals are expected to hinder growth of closed
blood sampling system market.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1642
Closed Blood Sampling System Market Drivers
Increasing number of surgical procedures is a major factor driving growth of global closed
blood sampling system market. According to the estimation of the World Health Organization,
266.2 to 359.5 million surgeries were performed in 2012, which was around 38% higher as
compared to the previous years and is expected to increase in the near future. Therefore,
increasing number of surgeries and emergency cases, and high demand for blood transfusion
increases the demand for closed blood sampling system. Moreover, studies by the National
Center for Biotechnology Information (NCBI) reported that the patients admitted in ICU are
majorly anemic and around 30 - 37% of the patients receive blood transfusion while admitted
in ICU, which also shows the rising need for closed blood sampling system.
In critically ill patients and patients under observation in ICU, blood sampling is frequently
done to monitor the hemodynamics. In conventional blood sampling systems, the blood sample
is withdrawn by removal of stopcock cap, which increases the risk of acquired blood stream
infection during sampling. Moreover, the unused blood is wasted in the case of conventional
sampling method. Closed blood sampling system is a solution to these problems. Furthermore,
the National Center for Biotechnology Information (NCBI) article suggests that the hemoglobin
and hematocrit counts shows minimal fluctuations when blood sampling is done by closed blood
sampling system.
Closed blood sampling systems are also used in pediatric patients, owing to easy
implementation, low cost, and significant reduction in blood loss. The patients in the intensive
care units (ICU) receive blood transfusion to treat low hemoglobin levels in patients with
critical illness. However, improper blood transfusion methods are mostly associated with
increased risk of morbidity and mortality. Various government regulatory organizations have
proposed guidelines to decrease the use of blood transfusions. For instance, the Canadian
Medical Association (CMA) released guidelines in 2008 in their Canadian Medical Association
Journal (CMAL), which was published in January 2008, to minimize the use of blood
transfusion in critically ill patients and closed blood sampling systems would be a method for
complying with these regulations.
Increasing demand for blood donations is also fueling the demand for closed blood sampling
systems. For instance, according to the World Health Organization (WHO), 112.5 million blood
donations were recorded globally and an increase of 10.7 million blood donations from unpaid
donors were reported from 2008 to 2013. Furthermore, according to the American National Red
Cross, around 7,000 units of platelets and 10,000 units of plasma are required daily in the U.S.
and nearly 21 million blood components are transfused each year in the U.S.
Closed Blood Sampling System Market - Regional Analysis
On the basis of region, closed blood sampling systems market is segmented into North America,
Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds dominant
position in closed blood sampling system market, followed by Asia Pacific. Increasing demand
for blood transfusions, owing to the increasing number of surgery or injury cases is driving
growth of closed blood sampling system market in North America. For instance, according to
the American National Red Cross, a humanitarian organization, around 21 million blood
components are transfused every year in the U.S.
Increasing demand for closed blood sampling systems with the establishment of new
hospitals, specialty clinics, and blood banks, and increasing demand for the usage of
blood components, owing to the increasing number of blood transfusion procedures is
fueling growth of closed blood sampling systems market in Asia Pacific. For instance,
according to the National AIDS Control Organization (NACO) 2014 data findings,
demand for blood and blood components in India is around 1% of the total population,
which is around 12 million blood units (1% of 1.2 billion populations). Moreover,
according to the Department of Control (DAC), India: 2013, the annual requirement of
blood was estimated to be 80 lakh units of blood between 2012 and 2013.
Report includes chapters which deeply display the following deliverable about industry :
• Closed Blood Sampling System Market Research Objective and Assumption
• Closed Blood Sampling System Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Closed Blood Sampling System Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Closed Blood Sampling System Market, By Regions
• Closed Blood Sampling System Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Closed Blood Sampling System Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Closed Blood Sampling System Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Closed Blood Sampling System Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Closed Blood Sampling System Market Competitive Landscape
Some of the key players operating in the closed blood sampling system market include Edwards
Lifesciences Crop, ICU Medical, Inc., Smiths Medical, CardioMed Supplies Inc., Argon Medical
Devices, Inc., Utah Medical Products, Inc., fannin Ltd., Velano Vascular, Inc., Ashcon
International Inc., and Merit Medical Systems, Inc. Key players in the market are focusing on
organic growth strategies, in order to enhance its market share and retain its competence in the
market. For instance, in January 2016, Velano Vascular, Inc., a medical device company that
manufactures needle-free, vascular device for blood collection received the U.S. FDA approval
for its updated version of needle-free blood draw device. The new Velano device is designed to
reduce blood draw related anxiety and discomfort in patients and also provides a safer work
environment for healthcare professionals.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1642
Closed Blood Sampling System Market Taxonomy:
By Product Type:
• Blood Sampling System
• Blood Sampling Accessories
By Application:
• Diagnostic
• Treatment
By End Users:
• Hospitals and Nursing Homes
• Blood Banks
• Surgical Clinics
• Diagnostic Centers
• Research and Academic Organizations
• Others
By Geography:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge186   documents Email
Document
Category
Health and Medicine
Views
5
File Size
144 KB
Tags
system, Closed Blood Sampling System Market
1/--pages
Report inappropriate content